Arthritis drug stops T-cells from going after joint tissue

The Bristol-Myers Squibb experimental medication works better to reduce joint pain in rheumatoid arthritis patients than conventional treatments, a study says. Researchers hope this drug, used in combination with other treatments, may achieve better results with fewer side effects.

View Full Article in:

Journal and Constitution (Atlanta) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ